ACETO to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
September 05, 2017 08:53 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Sept. 05, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Reports Fiscal 2017 Fourth Quarter and Full Year Results
August 24, 2017 17:00 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Aug. 24, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Board of Directors Declares Quarterly Cash Dividend
August 24, 2017 12:51 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Aug. 24, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Corporation Schedules Fourth Quarter & Fiscal 2017 Financial Results News Release and Conference Call
August 11, 2017 09:00 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Aug. 11, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Subsidiary, Rising Pharmaceuticals, Announces Product Launches
July 21, 2017 09:00 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., July 21, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO to Present at the Singular Summer Solstice Conference
July 07, 2017 09:00 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., July 07, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Subsidiary, Rising Pharmaceuticals, Launches Chlorthalidone Tablets, 25 mg and 50 mg, and Glipizide Extended Release Tablets, 2.5 mg, 5 mg and 10 mg
June 20, 2017 09:00 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., June 20, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Subsidiary, Rising Pharmaceuticals, Launches Atomoxetine Capsules, 10, 18, 25, 40, 60, 80 & 100 mg
May 31, 2017 10:42 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., May 31, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Reports Fiscal 2017 Third Quarter Results
May 04, 2017 17:00 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., May 04, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Board of Directors Declares Quarterly Cash Dividend
May 04, 2017 14:26 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., May 04, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...